L_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":607973816,"tweetId":"607973816","gmtCreate":1639481966010,"gmtModify":1639481966446,"author":{"id":3574922110603447,"idStr":"3574922110603447","authorId":3574922110603447,"authorIdStr":"3574922110603447","name":"Rolliopan","avatar":"https://static.tigerbbs.com/a76006b0036c2c9fde09d0a7571a72aa","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":42,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>L</body></html>","htmlText":"<html><head></head><body>L</body></html>","text":"L","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/607973816","repostId":1136423354,"repostType":4,"repost":{"id":"1136423354","kind":"news","pubTimestamp":1639481429,"share":"https://www.laohu8.com/m/news/1136423354?lang=&edition=full","pubTime":"2021-12-14 19:30","market":"us","language":"en","title":"58 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1136423354","media":"Benzinga","summary":"Gainers\n\nArena Pharmaceuticals, Inc. shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed","content":"Gainers\n<ul>\n <li>Arena Pharmaceuticals, Inc.&nbsp;shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.</li>\n <li>Foghorn Therapeutics Inc.&nbsp;shares jumped 55% to close at $18.58. Loxo Oncology, an R&amp;D group of Eli Lilly And CoLLY+0.07%, and Foghorn Therapeutics collaborated to create oncology medicines by applying Foghorn's Gene Traffic Control platform.</li>\n <li>BELLUS Health Inc.&nbsp;gained 48.2% to settle at $8.30 after the company announced topline data its Phase 2b SOOTHE trial of BLU-5937 in Refractory Chronic Cough.</li>\n <li>Petros Pharmaceuticals, Inc.&nbsp;surged 47.4% to close at $3.98 after gaining more than 14% on Friday.</li>\n <li>Energy Focus, Inc.&nbsp;gained 36.2% to close at $4.70.</li>\n <li>East Stone Acquisition Corporation&nbsp;jumped 31.4% to close at $18.40 after gaining over 8% on Friday.</li>\n <li>Puxin Limited&nbsp;climbed 27.1% to settle at $0.41 after tumbling over 10% on Friday.</li>\n <li>Biofrontera Inc.&nbsp;jumped 27% to close at $6.82. Biofrontera said it enrolled first patient to Phase IIb clinical study evaluating Ameluz / BF-RhodoLED for acne.</li>\n <li>Hudson Capital Inc.&nbsp;gained 25.5% to settle at $3.00.</li>\n <li>Mawson Infrastructure Group, Inc.&nbsp;shares surged 22.7% to close at $7.68.</li>\n <li>Reliance Global Group, Inc.&nbsp;jumped 22.6% to close at $2.55.</li>\n <li>Dingdong (Cayman) Limited&nbsp;gained 18.4% to settle at $15.61 on above average volume.</li>\n <li>Optical Cable Corporation&nbsp;jumped 17.9% to close at $5.60.</li>\n <li>Tabula Rasa HealthCare, Inc.&nbsp;rose 17.6% to close at $12.46.</li>\n <li>NeuroPace, Inc.&nbsp;gained 13.7% to close at $9.81.</li>\n <li>Clene Inc.&nbsp;climbed 13.1% to settle at $5.43.</li>\n <li>Tecnoglass Inc.&nbsp;gained 13% to close at $21.10.</li>\n <li>Huadi International Group Co., Ltd.&nbsp;jumped 13% to settle at $31.15.</li>\n <li>Turquoise Hill Resources Ltd.&nbsp;rose 12.9% to close at $16.48.</li>\n <li>Aziyo Biologics, Inc.&nbsp;jumped 12.6% to settle at $6.07 after a company late Friday director disclosed the purchase of 412,000 shares.</li>\n <li>Expro Group Holdings N.V.&nbsp;shares gained 11% to close at $15.03.</li>\n <li>GreenBox POS&nbsp;gained 9.4% to close at $4.88.</li>\n <li>Nautilus Biotechnology, Inc.&nbsp;gained 7.5% to close at $5.32.</li>\n <li>Sight Sciences, Inc.&nbsp;rose 6.6% to close at $20.39.</li>\n <li>Harley-Davidson, Inc.&nbsp;gained 4.7% to close at $38.54 after the company announced LiveWire, its EV motorcycle division, will become a separate publicly traded company through a merger with AEA-Bridges Impact Corp.</li>\n</ul>\nLosers\n<ul>\n <li>Nisun International Enterprise Development Group Co., Ltd&nbsp;shares dipped 60.3% to close at $4.38 on Monday after the company priced its $77 million underwritten public offering of common shares and pre-funded warrants to purchase common shares.</li>\n <li>X4 Pharmaceuticals, Inc.&nbsp;dipped 44.1% to settle at $2.14 after the company presented new clinical and scientific data at the 2021 ASH Annual Meeting.</li>\n <li>IGM Biosciences, Inc.&nbsp;dipped 41.3% to close at $29.25 after reporting Phase 1 trial data in advanced B-Cell malignancies. RBC Capital downgraded IGM Biosciences to Sector Perform from Outperform with a price target of $51, down from $90.</li>\n <li>Viomi Technology Co., Ltd&nbsp;dipped 30.9% to close at $2.30.</li>\n <li>Blonder Tongue Laboratories, Inc.&nbsp;fell 30.8% to settle at $0.6010 after the NYSE American said it will commence delisting proceedings against Blonder Tongue Laboratories.</li>\n <li>American Virtual Cloud Technologies, Inc.&nbsp;fell 26.2% to close at $1.85. The company recently announced it projects revenues of its Kandy Business Unit to grow from $14.3 million in 2020 to approximately $18.8 million in 2021 and in excess of $37 million in 2022.</li>\n <li>ALX Oncology Holdings Inc.&nbsp;dropped 24.2% to close at $23.56 as the company announced initial data from ASPEN-02, the ongoing Phase 1 / 2 study of Evorpacept in combination with Azacitidine at ASH 2021.</li>\n <li>Avenue Therapeutics, Inc.&nbsp;shares fell 24.2% to close at $1.00 after the company priced its $2.0 million underwritten public offering of common stock.</li>\n <li>Context Therapeutics Inc.&nbsp;shares fell 22.9% to close at $4.15 after dropping 14% on Friday. Context Therapeutics recently posted data from the window-of-opportunity trial of onapristone extended-release (ONA-XR) in postmenopausal patients with progesterone receptor-positive (PR+) early breast cancer.</li>\n <li>Allogene Therapeutics, Inc.&nbsp;fell 21.7% to close at $14.11 after the company reported updated data from two Phase 1 clinical trials of its lead anti-CD19 AlloCAR T therapy programs at the ASH 2021 Annual Meeting.</li>\n <li>Recruiter.com Group, Inc.&nbsp;dipped 20.5% to settle at $3.150 in sympathy with the overall market ahead of this week's Fed policy meeting.</li>\n <li>RCM Technologies, Inc.&nbsp;fell 20.2% to settle at $6.51.</li>\n <li>Focus Universal Inc.&nbsp;fell 19.9% to close at $12.02.</li>\n <li>Centrus Energy Corp.&nbsp;declined18.9% to settle at $47.04.</li>\n <li>Ensysce Biosciences, Inc.&nbsp;fell 18.1% to close at $3.63. Zacks Small-Cap Research, last week, gave the stock a $23 price valuation.</li>\n <li>iHuman Inc.&nbsp;fell 18% to close at $2.83.</li>\n <li>Renren Inc.&nbsp;fell 17.4% to settle at $10.34 after the company provided an update on a court order denying proposed settlement re shareholder derivative action.</li>\n <li>Volcon, Inc.&nbsp;dipped 17.3% to close at $9.44. Volcon inked a dealership agreement with Nash Powersports, an off-road dealership, to bring its line of electric Powersports vehicles to the West Coast.</li>\n <li>Solid Power Inc.&nbsp;fell 16.8% to settle at $9.58.</li>\n <li>Cingulate Inc.&nbsp;gained 16% to close at $3.09. The company recently priced its IPO at $6 per share.</li>\n <li>CollPlant Biotechnologies Ltd.&nbsp;dropped 15.8% to close at $13.75.</li>\n <li>PowerSchool Holdings, Inc.&nbsp;dropped 15.5% to close at $17.00 Goldman Sachs initiated coverage on PowerSchool with a Sell rating and announced a price target of $17.</li>\n <li>Wrap Technologies, Inc.&nbsp;fell 15.5% to settle at $4.04.</li>\n <li>GameStop Corp.&nbsp;shares dropped 14% to close at $136.88 .</li>\n <li>Autolus Therapeutics plc&nbsp;dropped 13% to close at $5.98.</li>\n <li>Zynex, Inc.&nbsp;fell 12% to settle at $9.884.</li>\n <li>TherapeuticsMD, Inc.&nbsp;fell 11.5% to close at $0.3991as the company said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submitted by the Company.</li>\n <li>Aprea Therapeutics, Inc.&nbsp;fell 10.9% to settle at $3.78. Aprea Therapeutics highlighted ASH presentation of primary analysis from Phase 2 trial of Eprenetapopt + Azacitidine.</li>\n <li>Vasta Platform Limited&nbsp;shares fell 9.2% to close at $4.0499 after jumping over 52% on Friday.</li>\n <li>Southwestern Energy Company&nbsp;shares declined 9.1% to close at $5.00 as the company announces pricing of 63,976,376 share block trade by selling shareholders for gross proceeds of $328.2 million.</li>\n <li>Zepp Health Corporation&nbsp;fell 8.7% to settle at $5.56.</li>\n <li>Bio-Path Holdings, Inc.&nbsp;fell 7.9% to close at $4.29 as the company presented data from ongoing Phase 2 study of Prexigebersen at 2021 American Society of Hematology Annual Meeting.</li>\n <li>Iteris, Inc.&nbsp;fell 7.9% to close at $3.99.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>58 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n58 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24587340/58-biggest-movers-from-yesterday>Benzinga</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nGainers\n\nArena Pharmaceuticals, Inc. shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.\nFoghorn ...\n\n<a href=\"https://www.benzinga.com/news/21/12/24587340/58-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","ARNA":"阿里那"},"source_url":"https://www.benzinga.com/news/21/12/24587340/58-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136423354","content_text":"Gainers\n\nArena Pharmaceuticals, Inc. shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.\nFoghorn Therapeutics Inc. shares jumped 55% to close at $18.58. Loxo Oncology, an R&D group of Eli Lilly And CoLLY+0.07%, and Foghorn Therapeutics collaborated to create oncology medicines by applying Foghorn's Gene Traffic Control platform.\nBELLUS Health Inc. gained 48.2% to settle at $8.30 after the company announced topline data its Phase 2b SOOTHE trial of BLU-5937 in Refractory Chronic Cough.\nPetros Pharmaceuticals, Inc. surged 47.4% to close at $3.98 after gaining more than 14% on Friday.\nEnergy Focus, Inc. gained 36.2% to close at $4.70.\nEast Stone Acquisition Corporation jumped 31.4% to close at $18.40 after gaining over 8% on Friday.\nPuxin Limited climbed 27.1% to settle at $0.41 after tumbling over 10% on Friday.\nBiofrontera Inc. jumped 27% to close at $6.82. Biofrontera said it enrolled first patient to Phase IIb clinical study evaluating Ameluz / BF-RhodoLED for acne.\nHudson Capital Inc. gained 25.5% to settle at $3.00.\nMawson Infrastructure Group, Inc. shares surged 22.7% to close at $7.68.\nReliance Global Group, Inc. jumped 22.6% to close at $2.55.\nDingdong (Cayman) Limited gained 18.4% to settle at $15.61 on above average volume.\nOptical Cable Corporation jumped 17.9% to close at $5.60.\nTabula Rasa HealthCare, Inc. rose 17.6% to close at $12.46.\nNeuroPace, Inc. gained 13.7% to close at $9.81.\nClene Inc. climbed 13.1% to settle at $5.43.\nTecnoglass Inc. gained 13% to close at $21.10.\nHuadi International Group Co., Ltd. jumped 13% to settle at $31.15.\nTurquoise Hill Resources Ltd. rose 12.9% to close at $16.48.\nAziyo Biologics, Inc. jumped 12.6% to settle at $6.07 after a company late Friday director disclosed the purchase of 412,000 shares.\nExpro Group Holdings N.V. shares gained 11% to close at $15.03.\nGreenBox POS gained 9.4% to close at $4.88.\nNautilus Biotechnology, Inc. gained 7.5% to close at $5.32.\nSight Sciences, Inc. rose 6.6% to close at $20.39.\nHarley-Davidson, Inc. gained 4.7% to close at $38.54 after the company announced LiveWire, its EV motorcycle division, will become a separate publicly traded company through a merger with AEA-Bridges Impact Corp.\n\nLosers\n\nNisun International Enterprise Development Group Co., Ltd shares dipped 60.3% to close at $4.38 on Monday after the company priced its $77 million underwritten public offering of common shares and pre-funded warrants to purchase common shares.\nX4 Pharmaceuticals, Inc. dipped 44.1% to settle at $2.14 after the company presented new clinical and scientific data at the 2021 ASH Annual Meeting.\nIGM Biosciences, Inc. dipped 41.3% to close at $29.25 after reporting Phase 1 trial data in advanced B-Cell malignancies. RBC Capital downgraded IGM Biosciences to Sector Perform from Outperform with a price target of $51, down from $90.\nViomi Technology Co., Ltd dipped 30.9% to close at $2.30.\nBlonder Tongue Laboratories, Inc. fell 30.8% to settle at $0.6010 after the NYSE American said it will commence delisting proceedings against Blonder Tongue Laboratories.\nAmerican Virtual Cloud Technologies, Inc. fell 26.2% to close at $1.85. The company recently announced it projects revenues of its Kandy Business Unit to grow from $14.3 million in 2020 to approximately $18.8 million in 2021 and in excess of $37 million in 2022.\nALX Oncology Holdings Inc. dropped 24.2% to close at $23.56 as the company announced initial data from ASPEN-02, the ongoing Phase 1 / 2 study of Evorpacept in combination with Azacitidine at ASH 2021.\nAvenue Therapeutics, Inc. shares fell 24.2% to close at $1.00 after the company priced its $2.0 million underwritten public offering of common stock.\nContext Therapeutics Inc. shares fell 22.9% to close at $4.15 after dropping 14% on Friday. Context Therapeutics recently posted data from the window-of-opportunity trial of onapristone extended-release (ONA-XR) in postmenopausal patients with progesterone receptor-positive (PR+) early breast cancer.\nAllogene Therapeutics, Inc. fell 21.7% to close at $14.11 after the company reported updated data from two Phase 1 clinical trials of its lead anti-CD19 AlloCAR T therapy programs at the ASH 2021 Annual Meeting.\nRecruiter.com Group, Inc. dipped 20.5% to settle at $3.150 in sympathy with the overall market ahead of this week's Fed policy meeting.\nRCM Technologies, Inc. fell 20.2% to settle at $6.51.\nFocus Universal Inc. fell 19.9% to close at $12.02.\nCentrus Energy Corp. declined18.9% to settle at $47.04.\nEnsysce Biosciences, Inc. fell 18.1% to close at $3.63. Zacks Small-Cap Research, last week, gave the stock a $23 price valuation.\niHuman Inc. fell 18% to close at $2.83.\nRenren Inc. fell 17.4% to settle at $10.34 after the company provided an update on a court order denying proposed settlement re shareholder derivative action.\nVolcon, Inc. dipped 17.3% to close at $9.44. Volcon inked a dealership agreement with Nash Powersports, an off-road dealership, to bring its line of electric Powersports vehicles to the West Coast.\nSolid Power Inc. fell 16.8% to settle at $9.58.\nCingulate Inc. gained 16% to close at $3.09. The company recently priced its IPO at $6 per share.\nCollPlant Biotechnologies Ltd. dropped 15.8% to close at $13.75.\nPowerSchool Holdings, Inc. dropped 15.5% to close at $17.00 Goldman Sachs initiated coverage on PowerSchool with a Sell rating and announced a price target of $17.\nWrap Technologies, Inc. fell 15.5% to settle at $4.04.\nGameStop Corp. shares dropped 14% to close at $136.88 .\nAutolus Therapeutics plc dropped 13% to close at $5.98.\nZynex, Inc. fell 12% to settle at $9.884.\nTherapeuticsMD, Inc. fell 11.5% to close at $0.3991as the company said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submitted by the Company.\nAprea Therapeutics, Inc. fell 10.9% to settle at $3.78. Aprea Therapeutics highlighted ASH presentation of primary analysis from Phase 2 trial of Eprenetapopt + Azacitidine.\nVasta Platform Limited shares fell 9.2% to close at $4.0499 after jumping over 52% on Friday.\nSouthwestern Energy Company shares declined 9.1% to close at $5.00 as the company announces pricing of 63,976,376 share block trade by selling shareholders for gross proceeds of $328.2 million.\nZepp Health Corporation fell 8.7% to settle at $5.56.\nBio-Path Holdings, Inc. fell 7.9% to close at $4.29 as the company presented data from ongoing Phase 2 study of Prexigebersen at 2021 American Society of Hematology Annual Meeting.\nIteris, Inc. fell 7.9% to close at $3.99.","news_type":1},"isVote":1,"tweetType":1,"viewCount":428,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/607973816"}